Oura
Oura makes a smart ring that tracks sleep, recovery, and other health signals.
On the record
Checkpoint: Confidential S-1 expected to become public ahead of IPO, revealing real margins and churn
The call
Oura leads a market it mostly built, protected by patents and health data, while Samsung's suit, Apple's silence, and its own IPO filing all sit unresolved.
Oura sells rings you wear that track sleep, heart rate, and other body signals, then gives you health insights through an app. The company has built up a collection of five years of health data from over five million customers, plus legal protections (patents) that have so far stopped Samsung from selling a competing ring in the U.S., though Samsung is fighting back in court. The hardest part for rivals to copy is having that massive pile of real health data to train their advice engine on, but Apple could muscle in if it releases its own ring, and free or cheaper alternatives could pull away budget-conscious customers. The big wildcard is whether Apple enters the ring market by late 2027 and whether Oura can prove it is actually making money before it goes public.
Why
01
AI pressure: None apparent. AI coaching needs Oura's proprietary sensor data to work, so Oura uses AI as an add-on, not a replacement threat. Could AI do the core job? Unlikely.
02
Bigger players: Apple. Apple has not shipped a smart ring; if it does, it could pull Watch users into a competing device fast. Could a giant copy it? No, they are blocked.
03
What protects it. Patents backed by ITC exclusion orders, 5.5M rings of longitudinal health data, and deep ties with Lilly, Dexcom, Quest, and the DoD.
What would change this call
Outcome of Samsung ITC patent litigation (pending as of Aug 2026). A loss for Oura could let Samsung erode ring share via design-around.
Oura's public S-1 filing (expected fall 2026) discloses churn, margins, CAC. Reveals whether subscription economics are healthy pre-IPO.
Whether Apple ships a competing ring product by end of 2027. Apple entry would test Oura's data and integration moat directly.
Oura's public S-1 filing (expected fall 2026) discloses churn, margins, CAC. Reveals whether subscription economics are healthy pre-IPO.
Whether Apple ships a competing ring product by end of 2027. Apple entry would test Oura's data and integration moat directly.
Key numbers
- 2025 revenue ~$1B, up from ~$225M in 2023
- 5.5M+ rings sold since 2015
- ~52-60% share of global smart ring market
Named risks
- Overheating/burn reports and law firm investigation into Ring 4, opened Feb 2026.
- Pending ITC litigation outcomes against Samsung, Reebok, Zepp Health, Noise filed Nov 2025.
- Pre-IPO financials (revenue, margins, subscription churn) are self-reported and unaudited.
- Subscription-free rivals (RingConn, Ultrahuman, Circular) undercut Oura's $5.99/month model.
- Apple entering the smart ring category could erode Oura's dominant share.
Rivals, as read in July 2026
| Rival | Direction | Evidence |
|---|---|---|
| Samsung | contesting | Galaxy Ring shipped July 2024; Oura filed ITC patent suit against Samsung Nov 2025 |
| Ultrahuman | losing to | Hit with ITC US import exclusion order effective Oct 2025, cited ~$50M lost sales (vendor-claimed) |
| Ultrahuman | gaining on | Leads India smart ring market with 30.4% share as of 2025 vs Oura's March 2026 entry |
| Apple | contesting | Has not shipped a ring as of mid-2026 but seen as the largest latent hardware threat |
| RingConn | losing to | Settled Oura's ITC case via patent license/royalty arrangement, continues selling in US |
| WHOOP | contesting | Rival wearable-health subscription model competing for same health-tracking budget |
Questions people ask
- Is Oura profitable in 2026?
- Oura says it is profitable, but this is self-reported and unaudited ahead of its IPO. The company reported roughly $1 billion in 2025 revenue, up about 100% year over year from roughly $225 million in 2023, per its September 22, 2025 press release.
- Could AI replace Oura's product?
- Unlikely soon. Oura's insight-generation layer uses AI (Oura Advisor, Counsel Health integration in Ring 5, shipped May 2026), but it depends on proprietary biometric data from its own ring hardware and 5.5 million+ devices sold, which generic AI assistants cannot replicate without the sensor.
- Who is Oura's biggest competitor?
- Samsung, via the Galaxy Ring launched July 2024, is Oura's most visible rival; Oura filed an ITC patent-infringement case against Samsung, Reebok, Zepp Health, and Noise in November 2025. Apple has not shipped a ring but is watched as the largest latent threat.
- Is Oura going public?
- Yes. Oura confidentially submitted a draft Form S-1 to the SEC on May 21, 2026, with underwriters reportedly including Goldman Sachs, Morgan Stanley, JPMorgan, Allen & Co., and Jefferies, following a $900M Series E at an ~$11 billion valuation in October 2025.
- Who owns Oura?
- Oura is privately venture-backed, led by CEO Tom Hale (since 2022). Its Series E of over $900 million, announced October 14, 2025, was led by Fidelity Management & Research with ICONIQ as a new investor, valuing the company at roughly $11 billion.
- Does the Oura Ring have safety problems?
- Reports of overheating and burn incidents surfaced on Reddit starting December 2025, prompting a law firm (Migliaccio & Rathod LLP) to open an investigation in February 2026 into Ring 4 battery drain, overheating, and tracking accuracy claims.
Timeline
- 2026-07-15Eli Lilly makes equity investment in Oura tied to GLP-1/connected care tools
- 2026-05-28Oura Ring 5 launches with ResMed cardio/respiratory pathway and Counsel Health AI doctor
- 2026-05-21Oura confidentially files draft S-1 with SEC for proposed IPO
- 2026-03-24Ultrahuman's redesigned Ring Pro gets CBP approval after ITC exclusion order
- 2026-02-10FDA revised General Wellness Policy for Low-Risk Devices takes effect
- 2026-01-08Oura discloses Nov 2025 ITC patent suit against Samsung, Reebok, Zepp Health, Noise
- 2025-10-21Oura secures ITC exclusion order ruling against Ultrahuman
- 2025-10-14Oura raises over $900M Series E at ~$11B valuation, passes 5.5M rings sold
- 2024-11Series D $200M raised at $5.2B valuation with Fidelity, Dexcom
- 2024-10US Department of Defense signs ~$96M supply agreement with Oura
Revision history
22 July 2026
First assessed. Defensible for now. The text above is fixed as of this date and is not edited afterwards.
In the same band
Sources
- ŌURA Surpasses 5.5 Million Rings Sold and Doubles Revenue (2025-09-22)
- Smart ring maker Oura raises $900M from Fidelity (2025-10-14)
- Ultrahuman ramps up US push with Ring Pro as Oura tightens grip (2026-03-24)
- Oura revenue, valuation & funding (2026-05-20)
- ŌURA Announces Confidential Submission of Draft Registration Statement (2026-05-21)
- ŌURA Raises Over $900M (2025-10-14)
- Oura unveils AI-enabled Oura Ring 5 (2026-06-02)
- Inside the Ring: Building Oura Ring 5 (2026-05-28)
- The Origins and Evolution of Oura Ring (2025-04-01)
- Introducing Metabolic Health at Oura (2025-05-06)
- New Oura Features (2026-06-30)
- Oura Health